Rolvedon Drug Interactions
Currently displaying a list of 177 drugs known to interact with Rolvedon (eflapegrastim).
- 3 major drug interactions
- 174 moderate drug interactions
Medications known to interact with Rolvedon
Note: Showing generic names only.
- abemaciclib
- acalabrutinib
- aldesleukin
- alemtuzumab
- altretamine
- arsenic trioxide
- asciminib
- asparaginase escherichia coli
- avapritinib
- axicabtagene ciloleucel
- azacitidine
- belantamab mafodotin
- belinostat
- bendamustine
- betibeglogene autotemcel
- bevacizumab
- bexarotene
- bleomycin
- blinatumomab
- bortezomib
- bosutinib
- brentuximab
- brexucabtagene autoleucel
- busulfan
- cabazitaxel
- capecitabine
- carboplatin
- carfilzomib
- carmustine
- chlorambucil
- ciltacabtagene autoleucel
- cisplatin
- cladribine
- clofarabine
- copanlisib
- crizotinib
- cyclophosphamide
- cytarabine
- cytarabine liposomal
- dacarbazine
- dactinomycin
- daratumumab
- dasatinib
- daunorubicin
- daunorubicin liposomal
- decitabine
- dinutuximab
- docetaxel
- doxorubicin
- doxorubicin liposomal
- duvelisib
- eflornithine
- elranatamab
- enfortumab vedotin
- epcoritamab
- epirubicin
- eribulin
- etoposide
- exagamglogene autotemcel
- ibritumomab
- ibrutinib
- idarubicin
- idecabtagene vicleucel
- idelalisib
- ifosfamide
- imatinib
- imetelstat
- inavolisib
- inotuzumab ozogamicin
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- interferon gamma-1b
- iobenguane I 131
- iodine i 131 tositumomab
- irinotecan
- irinotecan liposomal
- isatuximab
- ixabepilone
- ixazomib
- lenalidomide
- levamisole
- lifileucel
- lisocabtagene maraleucel
- lithium
- lomustine
- loncastuximab tesirine
- lovotibeglogene autotemcel
- lurbinectedin
- mechlorethamine
- melphalan
- melphalan flufenamide
- mercaptopurine
- methotrexate
- midostaurin
- mitomycin
- mitoxantrone
- mosunetuzumab
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- palbociclib
- panobinostat
- pazopanib
- pegaspargase
- peginterferon alfa-2a
- peginterferon alfa-2b
- pegloticase
- pegvaliase
- pemetrexed
- pentostatin
- pirtobrutinib
- plicamycin
- polatuzumab vedotin
- pomalidomide
- ponatinib
- pralatrexate
- procarbazine
- tafasitamab
- talazoparib
- talquetamab
- teclistamab
- temozolomide
- teniposide
- thalidomide
- thioguanine
- thiotepa
- tisagenlecleucel
- tisotumab vedotin
- topotecan
- tositumomab
- trabectedin
- trastuzumab
- trimetrexate
Report options
More about Rolvedon (eflapegrastim)
- Rolvedon consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: colony stimulating factors
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Zarxio
Zarxio (filgrastim-sndz) is biosimilar product used to treat neutropenia associated with ...
Neulasta
Neulasta is used to stimulate neutrophil growth and reduce infection risk (manifested by febrile ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Neupogen
Neupogen (filgrastim) is used to treat neutropenia, a lack of certain white blood cells caused by ...
Fulphila
Fulphila is used for febrile neutropenia, neutropenia associated with chemotherapy
Nivestym
Nivestym is used for bone marrow transplantation, neutropenia, neutropenia associated with ...
Udenyca
Udenyca is used for febrile neutropenia, hematopoietic syndrome of acute radiation syndrome ...
Releuko
Releuko is used for bone marrow transplantation, neutropenia, neutropenia associated with chemotherapy
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
